Cardiovascular dysregulation of miR‐17‐92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis
Laura S. Danielson(Columbia University Irving Medical Center), Eva Hernando(Eastern Cooperative Oncology Group), Noemí Rotllán(Instituto de Salud Carlos III), Carlos Fernández‐Hernando(Yale University), Glenn I. Fishman(New York University), María V. Guijarro(University of Florida), David Park(NYU Langone Health), Aránzazu Chamorro‐Jorganes(York University), Colin K. L. Phoon(York University)
Cited by 129
Related Papers
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
|Science|2010|1.3k
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k
ST-Segment Elevation in Patients with Covid-19 — A Case Series
|New England Journal of Medicine|2020|858
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
|Nature|2011|701
Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43
|Circulation Research|2001|686